A user experienced severe ankle swelling, pressure sensitivity, and bilateral tendonitis-like pain in their arms after starting a course of research-grade BPC-157. While other forum members were skeptical that the peptide caused these issues, the user planned to discontinue the protocol due to the inability to walk.